OQS
HALO icon

Occudo Quantitative Strategies’s Halozyme HALO Stock Holding History

Occudo Quantitative Strategies’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-18,228
Closed -$779K – 828
2020
Q4 		$779K Buy
+18,228
New +$655K 0.24% 109

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Occudo Quantitative Strategies's HALO Position: Q1 2021 in Review

Occudo Quantitative Strategies sold out of Halozyme (HALO) in Q1 2021, closing a stake of 18,228 shares — an estimated $779K sold.

Occudo Quantitative Strategies first reported a position in HALO in Q4 2020 and held it in 1 quarter. The position peaked at $779K in Q4 2020. 336 funds tracked by Wall St. Rank hold HALO as of Q1 2021.

  • Occudo Quantitative Strategies reported no remaining Halozyme position as of Q1 2021 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 18,228 Halozyme shares in Q1 2021, an estimated $779K.
  • Occudo Quantitative Strategies first reported a position in Halozyme in Q4 2020 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Halozyme position peaked at $779K in Q4 2020.
  • 336 funds tracked by Wall St. Rank held Halozyme as of Q1 2021.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2021, filed 14 May 2021.